These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 17221997)
1. Synthesis of the isonicotinoylnicotinamide scaffolds of the naturally occurring isoniazid-NAD(P) adducts. Delaine T; Bernardes-Génisson V; Meunier B; Bernadou J J Org Chem; 2007 Jan; 72(2):675-8. PubMed ID: 17221997 [TBL] [Abstract][Full Text] [Related]
2. 1H and 13C NMR characterization of pyridinium-type isoniazid-NAD adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis. Broussy S; Bernardes-Génisson V; Coppel Y; Quémard A; Bernadou J; Meunier B Org Biomol Chem; 2005 Feb; 3(4):670-3. PubMed ID: 15703806 [TBL] [Abstract][Full Text] [Related]
3. Studies on the 4-benzoylpyridine-3-carboxamide entity as a fragment model of the Isoniazid-NAD adduct. Broussy S; Bernardes-Génisson V; Gornitzka H; Bernadou J; Meunier B Org Biomol Chem; 2005 Feb; 3(4):666-9. PubMed ID: 15703805 [TBL] [Abstract][Full Text] [Related]
4. Binding of the tautomeric forms of isoniazid-NAD adducts to the active site of the Mycobacterium tuberculosis enoyl-ACP reductase (InhA): a theoretical approach. Stigliani JL; Arnaud P; Delaine T; Bernardes-Génisson V; Meunier B; Bernadou J J Mol Graph Model; 2008 Nov; 27(4):536-45. PubMed ID: 18955002 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles. Almeida da Silva PE; Ramos DF; Bonacorso HG; de la Iglesia AI; Oliveira MR; Coelho T; Navarini J; Morbidoni HR; Zanatta N; Martins MA Int J Antimicrob Agents; 2008 Aug; 32(2):139-44. PubMed ID: 18571384 [TBL] [Abstract][Full Text] [Related]
6. Insights from modeling the 3D structure of NAD(P)H-dependent D-xylose reductase of Pichia stipitis and its binding interactions with NAD and NADP. Wang JF; Wei DQ; Lin Y; Wang YH; Du HL; Li YX; Chou KC Biochem Biophys Res Commun; 2007 Jul; 359(2):323-9. PubMed ID: 17544374 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-inflammatory activity of newer quinazolin-4-one derivatives. Kumar A; Rajput CS Eur J Med Chem; 2009 Jan; 44(1):83-90. PubMed ID: 18501478 [TBL] [Abstract][Full Text] [Related]
8. Metabolism of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737): identification of an unusual N-acetylglucosamine conjugate in the cynomolgus monkey. Johnson BM; Kamath AV; Leet JE; Liu X; Bhide RS; Tejwani RW; Zhang Y; Qian L; Wei DD; Lombardo LJ; Shu YZ Drug Metab Dispos; 2008 Dec; 36(12):2475-83. PubMed ID: 18787055 [TBL] [Abstract][Full Text] [Related]
9. Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis. Dias MV; Vasconcelos IB; Prado AM; Fadel V; Basso LA; de Azevedo WF; Santos DS J Struct Biol; 2007 Sep; 159(3):369-80. PubMed ID: 17588773 [TBL] [Abstract][Full Text] [Related]
10. Chemical proteomics-based drug design: target and antitarget fishing with a catechol-rhodanine privileged scaffold for NAD(P)(H) binding proteins. Ge X; Wakim B; Sem DS J Med Chem; 2008 Aug; 51(15):4571-80. PubMed ID: 18616236 [TBL] [Abstract][Full Text] [Related]
11. A facile synthetic approach to 7-deazaguanine nucleosides via a Boc protection strategy. Wang RW; Gold B Org Lett; 2009 Jun; 11(11):2465-8. PubMed ID: 19422208 [TBL] [Abstract][Full Text] [Related]
12. A mechanistic study on the oxidation of hydrazides: application to the tuberculosis drug isoniazid. Amos RI; Gourlay BS; Schiesser CH; Smith JA; Yates BF Chem Commun (Camb); 2008 Apr; (14):1695-7. PubMed ID: 18368168 [TBL] [Abstract][Full Text] [Related]
14. Solution structure of a 2:1 C2-(2-naphthyl) pyrrolo[2,1-c][1,4]benzodiazepine DNA adduct: molecular basis for unexpectedly high DNA helix stabilization. Antonow D; Barata T; Jenkins TC; Parkinson GN; Howard PW; Thurston DE; Zloh M Biochemistry; 2008 Nov; 47(45):11818-29. PubMed ID: 18925745 [TBL] [Abstract][Full Text] [Related]
15. 2,6-Bis(azaindole)pyridine: reactivity with iron(III) and copper(II) salts. Collins SN; Taylor S; Krause JA; Connick WB Acta Crystallogr C; 2007 Oct; 63(Pt 10):m436-9. PubMed ID: 17917211 [TBL] [Abstract][Full Text] [Related]
16. Poly(amidosulfonic acid) modified glassy carbon electrode for determination of isoniazid in pharmaceuticals. Yang G; Wang C; Zhang R; Wang C; Qu Q; Hu X Bioelectrochemistry; 2008 Jun; 73(1):37-42. PubMed ID: 18499535 [TBL] [Abstract][Full Text] [Related]
17. Structures of the dI2dIII1 complex of proton-translocating transhydrogenase with bound, inactive analogues of NADH and NADPH reveal active site geometries. Bhakta T; Whitehead SJ; Snaith JS; Dafforn TR; Wilkie J; Rajesh S; White SA; Jackson JB Biochemistry; 2007 Mar; 46(11):3304-18. PubMed ID: 17323922 [TBL] [Abstract][Full Text] [Related]
19. [3 + 2] Cycloaddition reactions in the synthesis of triazolo[4,5-b]pyridin-5-ones and pyrrolo[3,4-b]pyridin-2-ones. Gao Y; Lam Y J Comb Chem; 2008; 10(2):327-32. PubMed ID: 18260650 [TBL] [Abstract][Full Text] [Related]
20. Monolayers of the lipid derivatives of isoniazid at the air/water interface and the formation of self-assembled nanostructures in water. Jin Y; Chen S; Xin R; Zhou Y Colloids Surf B Biointerfaces; 2008 Jul; 64(2):229-35. PubMed ID: 18329860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]